Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

Palliative radiotherapy for symptomatic and intact breast tumors must balance convenience, efficacy, and risk of acute toxicity. This case report presents a patient with metastatic breast cancer and an intact fungating primary tumor. She was treated with an ultrahypofractionated radiation therapy, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yejun, Nixon, Nancy, Cao, Jeffrey Q., Lee, Sangjune Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282535/
https://www.ncbi.nlm.nih.gov/pubmed/37350951
http://dx.doi.org/10.3389/fonc.2023.1171444
_version_ 1785061154652946432
author Hong, Yejun
Nixon, Nancy
Cao, Jeffrey Q.
Lee, Sangjune Laurence
author_facet Hong, Yejun
Nixon, Nancy
Cao, Jeffrey Q.
Lee, Sangjune Laurence
author_sort Hong, Yejun
collection PubMed
description Palliative radiotherapy for symptomatic and intact breast tumors must balance convenience, efficacy, and risk of acute toxicity. This case report presents a patient with metastatic breast cancer and an intact fungating primary tumor. She was treated with an ultrahypofractionated radiation therapy, 26 Gy in 5 consecutive daily fractions, with sequential palliative chemotherapy. This resulted in a minimal toxicity profile and significant reduction of tumor burden and symptoms.
format Online
Article
Text
id pubmed-10282535
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102825352023-06-22 Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma Hong, Yejun Nixon, Nancy Cao, Jeffrey Q. Lee, Sangjune Laurence Front Oncol Oncology Palliative radiotherapy for symptomatic and intact breast tumors must balance convenience, efficacy, and risk of acute toxicity. This case report presents a patient with metastatic breast cancer and an intact fungating primary tumor. She was treated with an ultrahypofractionated radiation therapy, 26 Gy in 5 consecutive daily fractions, with sequential palliative chemotherapy. This resulted in a minimal toxicity profile and significant reduction of tumor burden and symptoms. Frontiers Media S.A. 2023-06-07 /pmc/articles/PMC10282535/ /pubmed/37350951 http://dx.doi.org/10.3389/fonc.2023.1171444 Text en Copyright © 2023 Hong, Nixon, Cao and Lee https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Hong, Yejun
Nixon, Nancy
Cao, Jeffrey Q.
Lee, Sangjune Laurence
Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
title Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
title_full Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
title_fullStr Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
title_full_unstemmed Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
title_short Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
title_sort case report: ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282535/
https://www.ncbi.nlm.nih.gov/pubmed/37350951
http://dx.doi.org/10.3389/fonc.2023.1171444
work_keys_str_mv AT hongyejun casereportultrahypofractionatedpalliativebreastradiotherapyforafungatinginvasivemammarycarcinoma
AT nixonnancy casereportultrahypofractionatedpalliativebreastradiotherapyforafungatinginvasivemammarycarcinoma
AT caojeffreyq casereportultrahypofractionatedpalliativebreastradiotherapyforafungatinginvasivemammarycarcinoma
AT leesangjunelaurence casereportultrahypofractionatedpalliativebreastradiotherapyforafungatinginvasivemammarycarcinoma

Ejemplares similares